COX-2's Role in Gastric Cancer Angiogenesis
Author Information
Author(s): Liping Yao, Fei Liu, Hong Liu, Li Sun, Shuhui Liang, Kaichun Wu, Daiming Fan
Primary Institution: State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Hypothesis
The study aimed to investigate the effect of COX-2 siRNA on proliferation and angiogenesis of gastric cancer cells.
Conclusion
COX-2 might mediate tumor angiogenesis and growth, and could be considered as a target for gastric cancer therapy.
Supporting Evidence
- Down-regulation of COX-2 significantly inhibited the growth of gastric cancer cells in vitro and in vivo.
- 23 angiogenesis-related molecules were found to be involved in COX-2-induced angiogenesis suppression.
- COX-2 down-regulation suppressed the migration and tube formation of human umbilical vein endothelial cells.
Takeaway
This study found that reducing COX-2 in gastric cancer cells can slow down their growth and stop blood vessel formation, which is important for tumors to grow.
Methodology
The gastric cancer cell line SGC7901 was transfected with COX-2 siRNA, and growth and angiogenesis were assessed using in vitro and in vivo assays.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website